skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter, Ryan, and Team,

I realize that Couche-Tard has only 38 Russian stores. Do you think that management will be under pressure (like Magna for example) to divest their Russian operation? If it happens, what kind of effect could there be, both to their bottom line, as well as loss of "good will"? For example, Couche-Tard operates in several former eastern bloc countries such as Poland.

Thanks in advance for your insight.
Read Answer Asked by Jerry on March 07, 2022
Q: Enghouse has been mercilessly and relentlessly whacked all the way back down to near its March 2020 covid-panic-selling lows, a feat unmatched by most of the hardest-hit tech stocks. At what point (price) do you think it could be considered attractive on valuation? I can withstand the volatility, but given its global exposure (especially Europe) do you think it is prudent to crystallize a 20% tax-loss on it at this point in time?
Read Answer Asked by Peter on March 04, 2022
Q: This company is at March 2020 lows. Do you have conviction in this name or would you suggest putting sale proceeds into DSG, PBH or CAE for instance? I have plenty of IT exposure already. Thank you.
Read Answer Asked by Mark on March 04, 2022
Q: Hi!

I understand why Magna is down given their exposure to Russia and Belarus even though it is small, investors are selling everything associated with Russia. It seems over done since I'm sure Magna could pivot quite easily given the size of their overall operations and the proportion in the undesirable countries. I have starting building a position at these levels since it is approaching a 3% yield. Agree?

On the other hand, not sure what is going on with Aritzia. Down from $58 to below $45. Is the market anticipating a recession? Doesn't seem like their manufacturing is affected by the War. Having a hard time making sense of this given Aritzia's momentum prior to the War and strong earnings reports.

Thanks,
Jason
Read Answer Asked by Jason on March 04, 2022
Q: Good morning, Do you think these two stocks TOI and ATZ have decent recovery potential in the short term, hopefully this year, or would you say they both need different market conditions to recover to their previous highs, thanks?
Read Answer Asked by Pat on March 04, 2022
Q: Dear 5i team.

I see AT is set to report 3/10. In view of this, can you let us know what is expected and what your educated guess would be if they miss/beat? In other words, your opinion on risk reward from these levels would be appreciated.

Many thanks.
Read Answer Asked by Arthur on March 04, 2022
Q: I find myself on the fence with Savaria. I have held it a long time and consequently have had it grow from a partial position initially to full position without adding to it. With interest rates due to rise I assume it will cost SIS more to service their debt (eventually at least), and if inflation continues to run I would prefer owning a company that has demonstrated an ability to increase their dividend. In your last report, under “Valuation” you state “… we expect SIS to maintain its record of annual dividend increases”, but I note in the Report Card of that same report it gives 5 Yr Dividend Growth a C rating and what looks like a -25%? Can you please comment?
Thanks,
Read Answer Asked by Stephen R. on March 02, 2022
Q: Hello

I have about $25K in cash to invest with a 15 year time horizon. I own many of your balanced and income portfolio CO’s already, I probably own too many with 25-30 in my portfolio that’s high 6 figures. I don’t own these 2 - GSY or SHOP.

Would you recommended added these two new positions to my portfolio, or just increase positions with my current names - WSP, TFII, BAM.a, the banks, etc.


Thanks,
Read Answer Asked by Cam on March 01, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!